| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/JTO.0B013E31818DDA9D |
| P698 | PubMed publication ID | 19057260 |
| P2093 | author name string | Gwyn Bebb | |
| Shannon Otsuka | |||
| P2860 | cites work | Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 |
| Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space | Q40607879 | ||
| P433 | issue | 12 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 1379-1383 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer | |
| P478 | volume | 3 |
| Q35109520 | A Preclinical Evaluation of Antrodia camphorata Alcohol Extracts in the Treatment of Non-Small Cell Lung Cancer Using Non-Invasive Molecular Imaging |
| Q48363650 | Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors |
| Q35181573 | CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro |
| Q36583985 | CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential |
| Q37856648 | Chronic obstructive pulmonary disease and lung cancer: new molecular insights |
| Q35604189 | Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancer |
| Q35550241 | Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
| Q34342390 | Differential expression of SDF-1 isoforms in bladder cancer |
| Q38007549 | Immune alterations and emerging immunotherapeutic approaches in lung cancer |
| Q84996864 | Lung defects in neonatal and adult stromal-derived factor–1 conditional knockout mice |
| Q37684330 | Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. |
| Q41709278 | Novel pleiotropic effects of bioactive phospholipids in human lung cancer metastasis |
| Q34009162 | Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas |
| Q28394867 | Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy |
| Q39097274 | Potentiation of EBV-induced B Cell transformation by CXCR4-tropic, but not CCR5-tropic, HIV gp120: implications for HIV-associated lymphomagenesis |
| Q43067202 | Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment |
| Q36811784 | Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? |
| Q47176774 | Stemness-Related Markers in Cancer |
| Q92592300 | Stromal Cell-derived Factor-1 and CXC Chemokine Receptor Type-4 are Associated with Cardiovascular Disease in Patients under Hemodialysis |
| Q60926729 | The Emerging Role of TYRO3 as a Therapeutic Target in Cancer |
| Q34284208 | The balance between two isoforms of LEF-1 regulates colon carcinoma growth |
| Q84239888 | The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis |
| Q38016208 | Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention |
Search more.